Document is current
Any future updates will be listed below
-
Authors
Vasconcelos, Alex T.
Rosa, Lucas A.
De Fendi, Lígia I.
Fontes, Vítor J. B.
Garcia, Denny M.
Cardoso, George C.
De Moraes, Carlos Gustavo
Paula, Jayter S. https://orcid.org/0000-0002-8111-3810
-
Funding
Funding for this research was provided by:
Fundação de Amparo à Pesquisa do Estado de São Paulo (2019/03027-3)
Coordenação de Aperfeiçoamento de Pessoal de Nível Superior
- License Information
-
More Information
Article History
Received: 27 March 2024
Revised: 14 August 2024
Accepted: 27 September 2024
First Online: 9 October 2024
Declarations
:
: All procedures performed in studies involving human participants were in accordance with the ethical standards of the Research Ethics Committee at University of São Paulo, Ribeirão Preto (Process number: 3.365.208) and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.
: Informed consent was obtained from all individual participants included in the study.
: Alex T. Vasconcelos, Lucas A. Rosa, Lígia I. De Fendi, Vítor J. B. Fontes, Denny M. Garcia, and George C. Cardoso certify that they have no affiliations with or involvement in any organization or entity with any financial interest, or non-financial interest in the subject matter or materials discussed in this manuscript.Potential Conflicts:Carlos Gustavo de Moraes: Code C (Consultant/Contractor): Carl Zeiss, Novartis, Perfuse Therapeutics, Thea Pharma, Galimedix; Code R (Research): Topcon, Carl Zeiss, RPB, CDC, NIH; Code E (Employment): Ora Clinical.Jayter Silva Paula: Code C (Consultant/Contractor): Abbvie Inc.; Code R (Research): The São Paulo Research Foundation: FAPESP.
